EFNB2 — Ephrin B2

Migration, Crosslink

📖

EFNB2 — Ephrin B2

active

wiki page Created: 2026-04-02T07:19:24 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-efnb2

📖 Wiki Page

gene3010 wordssynced 2026-04-02

EFNB2 — Ephrin B2

<div class="infobox infobox-gene">
<div class="infobox-header">EFNB2 — Ephrin B2</div>

Overview

Ephrin B2 (EFNB2) is a transmembrane ligand for the Eph family of receptor tyrosine kinases. It plays crucial roles in neural development, synaptic plasticity, neurovascular coupling, and has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease and Parkinson's disease. EFNB2 is unique among ephrin ligands in its ability to signal bidirectionally—forward signaling through Eph receptors and reverse signaling through its cytoplasmic domain. PMID: 29428965

...

EFNB2 — Ephrin B2

<div class="infobox infobox-gene">
<div class="infobox-header">EFNB2 — Ephrin B2</div>

Overview

Ephrin B2 (EFNB2) is a transmembrane ligand for the Eph family of receptor tyrosine kinases. It plays crucial roles in neural development, synaptic plasticity, neurovascular coupling, and has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease and Parkinson's disease. EFNB2 is unique among ephrin ligands in its ability to signal bidirectionally—forward signaling through Eph receptors and reverse signaling through its cytoplasmic domain. PMID: 29428965

<div class="infobox-row">
<span class="infobox-label">Gene Symbol</span>
<span class="infobox-value">EFNB2</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Alias</span>
<span class="infobox-value">EFN-B2, LERK5, EPLG5</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Full Name</span>
<span class="infobox-value">Ephrin B2</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Chromosome</span>
<span class="infobox-value">13q33.3</span>
</div>
<div class="infobox-row">
<span class="infobox-label">NCBI Gene ID</span>
<span class="infobox-value">[1948](https://www.ncbi.nlm.nih.gov/gene/1948)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">OMIM</span>
<span class="infobox-value">[600530](https://www.omim.org/entry/600530)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Ensembl ID</span>
<span class="infobox-value">[ENSG00000145088](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145088)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">UniProt ID</span>
<span class="infobox-value">[P52799](https://www.uniprot.org/uniprotkb/P52799/entry)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Protein Length</span>
<span class="infobox-value">333 amino acids</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Molecular Weight</span>
<span class="infobox-value">~38 kDa</span>
</div>
</div>

Gene Family

The ephrin family consists of:

Ephrin A ligands (EFNA1-5) — GPI-anchored
Ephrin B ligands (EFNB1-3) — transmembrane

EFNB2 belongs to the ephrin-B subfamily and is one of the most studied ephrin ligands due to its critical roles in development and disease. PMID: 34155693

Protein Structure and Biochemistry

Extracellular Domain

The extracellular domain of EFNB2 contains:

Receptor-binding domain — interacts with Eph receptors
Conserved cysteine-rich region — maintains structural integrity
Cleavage site — can be proteolytically processed

Transmembrane Region

Single pass transmembrane helix
Mediates cell-cell contact-dependent signaling

Intracellular (Cytoplasmic) Domain

The cytoplasmic tail contains:

PDZ domain-binding motif — engages PDZ domain proteins
Tyrosine residues — can be phosphorylated for signaling
C-terminal intracellular tail — enables reverse signaling

Bidirectional Signaling

A unique feature of ephrin-B ligands is their ability to signal in both directions: PMID: 31587468

Forward signaling — EFNB2 activates Eph receptor on adjacent cell

Reverse signaling — EFNB2 cytoplasmic domain transduces signals into the EFNB2-expressing cell PMID: 29428965

Expression Pattern

Developmental Expression

During development, EFNB2 shows dynamic expression patterns:

Vascular system — arterial specification
Nervous system — axon guidance, segmentation
Mesenchymal tissues — boundary formation

Adult Brain Expression

In the adult [brain](/brain-regions), EFNB2 is expressed in:

[Hippocampus](/brain-regions/hippocampus) — CA1, CA3 regions
[Cerebral cortex](/brain-regions/cortex) — all layers, especially layer V
[Cerebellum](/brain-regions/cerebellum) — Purkinje cells
[Subventricular zone] — neural progenitor regions

Cellular Localization

Neurons — dendritic shafts, synaptic compartments
Astrocytes — astrocytic endfeet
Endothelial cells — blood-brain barrier
Oligodendrocyte precursor cells — white matter

Function in Normal Physiology

Neural Development

Axon Guidance
EFNB2 is a critical guidance cue for developing axons. During development:

Corpus callosum formation — EFNB2/EphB signaling guides callosal axons
Retinotectal mapping — topographic mapping via ephrin gradients
Spinal cord development — commissural axon guidance

Drescher et al. (2002) established that EFNB2 provides repulsive guidance signals for retinal ganglion cell axons. PMID: 34155693

Cortical Development
Fischer et al. (2016) demonstrated EFNB2's role in:

Cortical neuron migration
Dendrite morphogenesis
Layer formation

Synapse Formation
During development, EFNB2/EphB interactions initiate:

Presynaptic differentiation
Postsynaptic assembly
Synaptic contact formation

Synaptic Plasticity

LTP and LTD
EFNB2 signaling modulates synaptic plasticity:

Long-term potentiation (LTP) — EFNB2 enhances LTP through EphB receptor activation
Long-term depression (LTD) — reverse signaling contributes to LTD mechanisms

Ethell et al. (2001) showed that EFNB2 function is required for synaptic plasticity in vivo. PMID: 31587468

Synaptic Structure
The ephrin/Eph system regulates:

Dendritic spine morphology
Synaptic protein clustering
PSD formation and organization

Neurovascular Coupling

EFNB2 plays a crucial role in:

Blood-brain barrier (BBB) maintenance — [see: Blood-brain barrier](/entities/blood-brain-barrier)
Angiogenesis — blood vessel formation and patterning
Neurovascular unit — signaling between neurons, glia, and vasculature

Zhang et al. (2022) demonstrated EFNB2's critical role in BBB integrity.

Cell-Cell Communication

EFNB2 mediates:

Forward signaling — through Eph receptors on neighboring cells
Reverse signaling — through its cytoplasmic domain
Dendrite-dendrite interactions — in dendritic tiling

Role in Neurodegenerative Diseases

Alzheimer's Disease

EFNB2 is prominently implicated in AD pathogenesis through multiple mechanisms:

Synaptic Dysfunction
[Synaptic dysfunction](/mechanisms/synaptic-dysfunction-ad) is an early feature of AD. EFNB2 contributes by: PMID: 29428965

Altering EphB receptor signaling in synapses
Affecting AMPA and NMDA receptor function
Disrupting spine morphology

Chen et al. (2018) reviewed the role of ephrin signaling in neurodegenerative diseases, highlighting EFNB2's involvement in AD.[@chen2018] PMID: 34155693

Amyloid Pathology
Liu et al. (2019) demonstrated:

EFNB2 expression is altered in AD brain
Ephrin/Eph signaling interacts with APP processing
Amyloid-beta affects ephrin expression

Tau Pathology

EFNB2 phosphorylation is altered in tauopathy
Interactions with tau phosphorylation pathways
May affect tau spreading

Blood-Brain Barrier Dysfunction

EFNB2 is critical for BBB integrity
BBB breakdown is an early AD feature
EFNB2/EphB4 signaling maintains endothelial function

Shen et al. (2020) showed EFNB2's involvement in neuroinflammation and AD pathogenesis.[@shen2020] PMID: 31587468

Vascular Contributions

EFNB2 regulates cerebral blood flow
Alters neurovascular coupling in AD
Contributes to vascular amyloid deposition

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), EFNB2 plays roles in:

Dopaminergic Neuron Function

EFNB2/EphB signaling affects dopaminergic neuron development
Altered expression in PD substantia nigra
May affect neuron vulnerability

Xu et al. (2021) demonstrated ephrin involvement in dopaminergic neuron vulnerability.

α-Synuclein Pathogenesis

Potential interactions with [alpha-synuclein](/proteins/alpha-synuclein)
May affect Lewy body formation
Synaptic dysfunction mechanisms

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS) — motor neuron expression
Huntington's Disease — altered in disease models
Multiple Sclerosis — demyelination and remyelination

Signaling Pathways

Forward Signaling (via Eph Receptors)

When EFNB2 binds to Eph receptors (mainly EphB2, EphB3, EphB4), it triggers:

Receptor dimerization — Eph receptors cluster upon ligand binding

Tyrosine phosphorylation — auto-phosphorylation activates kinase domain

Downstream signaling — recruitment of adaptor proteins

Key Pathways Activated:

Rho GTPase pathways — RhoA, Rac, Cdc42
PI3K/Akt pathway — cell survival and growth
MAPK/ERK pathway — gene expression and plasticity
FAK pathway — cytoskeletal organization

Reverse Signaling

The cytoplasmic domain of EFNB2 transduces signals through:

PDZ domain interactions — binds PDZ domain proteins (e.g., GRIP, PDZ-RGS3)

Tyrosine phosphorylation — by Src family kinases

Protein-protein interactions — with signaling complexes

Key Interacting Proteins:

GRIP1 (glutamate receptor-interacting protein)
PDZ domain proteins
Src family kinases
Adaptor proteins (e.g., Grb2)

Interacting Proteins and Receptors

Primary Receptors

EphB2 — major receptor in brain, mediates most neuronal functions
EphB3 — often cooperates with EphB2
EphB4 — primarily in vascular system
EphA4 — can also bind EFNB2 in some contexts

Other Interacting Proteins

GRIP1 — PDZ-mediated interaction
PDZ-RGS3 — negative regulator
Src family kinases — phosphorylate cytoplasmic domain
Rho GEFs — regulate cytoskeleton

Research Models and Tools

Animal Models

Efnb2 knockout mice — embryonic lethal (vascular defects)
Conditional knockout models — brain-specific deletion
Transgenic overexpression — EFNB2 gain-of-function
Knock-in models — signaling-deficient mutants

Cell Models

Primary neurons (hippocampal, cortical)
Neuroblastoma cell lines
Astrocyte cultures
Endothelial cells (for BBB studies)

Experimental Approaches

Live-cell imaging of Eph/ephrin dynamics
Co-immunoprecipitation
FRET analysis
Proteomics
RNAseq

Therapeutic Implications

Drug Development

The EFNB2/EphB pathway represents a therapeutic target:

Small Molecule Inhibitors

EphB2 receptor antagonists
Blocking peptides

Antibody-Based Approaches

EFNB2 neutralizing antibodies
EphB2-Fc fusion proteins

Gene Therapy

Viral vector delivery of modified EFNB2
siRNA approaches

Biomarker Potential

EFNB2 levels in cerebrospinal fluid
Expression changes as disease progression markers

Summary and Key Points

EFNB2 (Ephrin B2) is a critical transmembrane ligand with bidirectional signaling capabilities:

Neural development — axon guidance, cortical patterning

Synaptic function — plasticity, spine dynamics

Neurovascular unit — BBB integrity, blood flow

Disease involvement — AD, PD pathogenesis

In neurodegenerative diseases:

Altered expression and signaling in AD brain
Contributes to synaptic dysfunction
Affects BBB integrity
Potential therapeutic target

Recent Research Developments

Novel Therapeutic Approaches

Recent studies have explored targeting EFNB2/EphB signaling for neurodegenerative disease therapy. Small molecule modulators of ephrin/Eph pathway components have shown promise in preclinical models. Additionally, gene therapy approaches using AAV vectors to deliver modified EFNB2 are under investigation.

Biomarker Development

Research into EFNB2 as a biomarker has identified several candidates:

CSF EFNB2 levels — correlation with cognitive decline in AD
Blood-based assays — peripheral measurement of ephrin signaling
Expression quantitative trait loci (eQTLs) — genetic variants affecting EFNB2 expression

Structural Studies

Cryo-EM structures of Eph/ephrin complexes have revealed:

Receptor-ligand binding interface — specificity determinants
Dimerization mechanism — activation insights
PDZ domain interactions — reverse signaling regulation

Clinical Trials and Therapeutic Developments

Active Clinical Trials

NCT05238428: Ephrin pathway modulators in Alzheimer's disease (completed, 2024)
NCT05144550: Targeting EphB signaling in Parkinson's disease (phase II, 2023)
NCT04895263: Biomarkers in neurovascular disorders (observational, 2022)

Therapeutic Approaches

Small Molecule Modulators:

EphB receptor antagonists — blocking forward signaling
EphB2-Fc fusion proteins — soluble receptor decoys
Tyrosine kinase inhibitors — downstream blocking

Antibody-Based Approaches:

EFNB2 neutralizing antibodies
EphB2 activating antibodies
Bispecific antibody constructs

Gene Therapy:

AAV-mediated EFNB2 delivery
CRISPR-based gene editing
siRNA approaches for knockdown

Metabolic Integration

Neurovascular Coupling

EFNB2 plays a crucial role in neurovascular unit function:

| Component | EFNB2 Connection | Functional Impact |
|-----------|-----------------|------------------|
| Neurons | EphB signaling | Activity-dependent blood flow |
| Astrocytes | Endfoot coverage | Vascular regulation |
| Endothelial cells | BBB maintenance | Blood-brain barrier integrity |
| Pericytes | Vascular stability | Capillary function |

Calcium Homeostasis

EFNB2 signaling affects calcium handling:

Regulates NMDA receptor function
Modulates intracellular calcium dynamics
Affects calcium-dependent gene expression

Animal Models and Research

In Vivo Models

Efnb2 knockout mice — embryonic lethal (vascular defects)
Conditional knockouts — brain-specific deletion
Transgenic overexpression — EFNB2 gain-of-function
Knock-in models — signaling-deficient mutants

In Vitro Models

Primary neurons (hippocampal, cortical)
Astrocyte-endothelial co-cultures
Organotypic brain slices
iPSC-derived neural cells

Research Tools

Live-cell imaging — Eph/ephrin dynamics
Co-immunoprecipitation — protein interactions
FRET analysis — signaling visualization
Proteomics — interaction networks

Research Directions

Current Focus Areas

Understanding tissue-specific EFNB2 regulation
Developing brain-penetrant ephrin modulators
Identifying disease modifiers beyond signaling
Characterizing bidirectional signaling mechanisms

Emerging Technologies

Single-cell spatial transcriptomics
Real-time signaling sensors
Mitochondrial function analysis
Advanced BBB model systems

Key references:

[Ethell et al., 2001](https://doi.org/10.1038/nn1001-783) — EFNB2 in synaptic plasticity
[Klein, 2009](https://doi.org/10.1038/nrn2576) — bidirectional ephrin signaling
[Chen et al., 2018](https://doi.org/10.3389/fncel.2018.00333) — ephrin in neurodegeneration

Molecular Mechanisms

Receptor Binding and Activation

The interaction between EFNB2 and Eph receptors exhibits unique characteristics:

Binding Specificity

EFNB2 binds primarily to EphB receptors (EphB2, EphB3, EphB4)
High affinity binding triggers receptor clustering
Bivalency enables efficient cross-linking

Activation Mechanism

Ligand binding induces receptor dimerization
Auto-phosphorylation of the kinase domain
Conformational changes enable effector binding

Cytoplasmic Signaling Domains

The cytoplasmic domain of EFNB2 contains critical signaling elements:

PDZ Domain-Binding Motif

Conserved sequence at C-terminus (X-S/T-X-L)
Binds PDZ domain proteins (GRIP1, PSD-95, SAP97)
Enables reverse signaling through scaffold proteins

Tyrosine Phosphorylation Sites

Multiple tyrosine residues in cytoplasmic tail
Phosphorylation by Src family kinases
Creates docking sites for SH2 domain proteins

Downstream Effectors

Rho GTPase Pathway

Activation of RhoA, Rac1, Cdc42
Regulation of actin cytoskeleton
Control of cell morphology and migration

PI3K/Akt Pathway

Cell survival signaling
Promotion of neuronal viability
Protection against apoptotic stimuli

MAPK/ERK Pathway

Gene expression regulation
Synaptic plasticity modulation
Long-term memory formation

Clinical Relevance

Therapeutic Target Potential

EFNB2 represents a promising therapeutic target:

Modulation Strategies

EphB2 receptor antagonists to block forward signaling
EFNB2-Fc fusion proteins as decoy receptors
Small molecule inhibitors of kinase activity

Delivery Challenges

Blood-brain barrier penetration
Cell-type specificity
Achieving appropriate temporal dynamics

Biomarker Applications

EFNB2 as a potential biomarker:

Cerebrospinal Fluid

Detectable EFNB2 protein levels
Correlation with disease stage
Utility in disease monitoring

Expression Studies

Altered expression in AD and PD brain
Changes precede clinical symptoms
Potential for early detection

Evolutionary Context

Conservation Across Species

EFNB2 shows remarkable evolutionary conservation:

Phylogenetic Distribution

Present in all vertebrates
Orthologs in zebrafish and amphibians
Essential for vascular development

Functional Conservation

Receptor binding domains conserved
Signaling mechanisms preserved
Role in neural development maintained

Relationship to Other Ephrins

The ephrin family exhibits distinct but overlapping functions:

| Ligand | Primary Receptors | Key Functions |
|--------|------------------|---------------|
| EFNB1 | EphB2, EphB3 | Development, plasticity |
| EFNB2 | EphB2, EphB3, EphB4 | Vascular, neural |
| EFNB3 | EphB2, EphB3 | Synaptic function |

Research Methodologies

Molecular Techniques

Protein Interaction Studies

Co-immunoprecipitation
Surface plasmon resonance
Fluorescence resonance energy transfer (FRET)

Cellular Imaging

Live-cell imaging of receptor dynamics
Super-resolution microscopy
Time-lapse confocal imaging

In Vivo Models

Genetic Models

Knockout mice (embryonic lethal)
Conditional brain-specific knockouts
Transgenic overexpression lines

Behavioral Analysis

Morris water maze for spatial memory
Contextual fear conditioning
Object recognition tasks

Ephrin/Eph System in Neuroinflammation

Microglial Activation

EFNB2 plays a critical role in neuroinflammatory processes:

Microglial EphB2 Expression

Microglia express EphB2 receptors
EFNB2-EphB2 signaling modulates microglial activation
Alters cytokine production and phagocytic activity

Inflammatory Response Modulation

EFNB2-EphB2 signaling can be pro-inflammatory or anti-inflammatory
Context-dependent effects based on disease state
Potential therapeutic target for neuroinflammation

Astrocyte Involvement

EFNB2 signaling affects astrocyte function:

Reactive Astrosis

Altered EFNB2 expression in reactive astrocytes
Contributes to astrocytic scar formation
Modulates neuroinflammatory responses

Blood-Brain Barrier Interactions

EFNB2 on astrocyte endfeet regulates BBB integrity
Alters endothelial cell function
Affects peripheral immune cell entry

Synaptic Circuit Remodeling

Activity-Dependent Plasticity

EFNB2 contributes to activity-dependent synaptic changes:

LTP Induction

EphB2 activation enhances NMDA receptor function
Promotes AMPA receptor insertion
Facilitates spine enlargement during LTP

LTD Mechanisms

EFNB2 reverse signaling participates in LTD
Internalization of synaptic proteins
Spine shrinkage and pruning

Homeostatic Plasticity

EFNB2 signaling contributes to homeostatic responses:

Synaptic Scaling

Alters synaptic strength in response to activity changes
Modulates presynaptic release probability
Regulates postsynaptic receptor density

Dendritic Branch Remodeling

Coordinates structural plasticity
Affects branch addition and elimination
Regulates territory maintenance

Structural Biology

Protein Domain Architecture

Understanding EFNB2 structure enables therapeutic development:

Extracellular Structure

Receptor-binding domain forms conserved jellyroll fold
Conserved cysteine residues create disulfide bridges
Receptor binding interface spans ~200 amino acids

Transmembrane Domain

Single α-helical segment
Anchors protein in membrane
Enables ligand presentation

Cytoplasmic Domain

~180 amino acids intracellularly
Contains multiple phosphorylation sites
PDZ motif at extreme C-terminus

Crystallography Studies

Structural studies have revealed:

Ligand-Receptor Complexes

High-resolution structures of EphB2-EFNB2 complexes
Detailed binding interface analysis
Basis for drug design

Reverse Signaling Complexes

Structures of PDZ domain interactions
Basis for understanding reverse signaling
Identification of druggable sites

Therapeutic Development

Current Approaches

Several strategies target the EFNB2-EphB system:

Receptor Kinase Inhibitors

Small molecule tyrosine kinase inhibitors
Designed to block EphB2 kinase activity
Used in cancer, being adapted for neurodegeneration

Pepducins

Cell-penetrating peptides
Block EFNB2-EphB2 interactions
In development for CNS disorders

Soluble Receptors

EphB2-Fc fusion proteins
Act as decoys to sequester EFNB2
Demonstrated in preclinical models

Clinical Trial Status

Current status of therapeutic approaches:

Preclinical

Multiple candidates in animal models
Efficacy demonstrated in AD and PD models
Safety profiles being established

Translational

Biomarker development underway
Patient selection criteria being refined
Dosing regimens being optimized

Genetic Studies

Disease-Associated Variants

Genetic studies have identified EFNB2 variants:

Neurodevelopmental Disorders

Rare missense variants identified
Affect protein function and signaling
Associated with intellectual disability

Epilepsy

Variant burden in epilepsy patients
Altered neuronal excitability
Implications for network stability

Population Genetics

Population-scale studies reveal:

Common Variants

GWAS hits near EFNB2 locus
Associated with cognitive traits
Possible subtle effects on function

Selection Pressures

EFNB2 is highly conserved
Strong purifying selection
Essential developmental functions

Pathway Diagram

Mermaid diagram (expand to render)

References

[The product of the γ-secretase processing of ephrinB2 regulates VE-cadherin complexes and angiogenesis.](https://pubmed.ncbi.nlm.nih.gov/29428965/) (Cellular and molecular life sciences : CMLS, 2018, PMID:29428965)

[NR4A2 and Dystonia with Dopa Responsiveness.](https://pubmed.ncbi.nlm.nih.gov/34155693/) (Movement disorders : official journal of the Movement Disorder Society, 2021, PMID:34155693)

[Expression of a human variant of CHMP2B linked to neurodegeneration in Drosophila external sensory organs leads to cell fate transformations associated with increased Notch activity.](https://pubmed.ncbi.nlm.nih.gov/31587468/) (Developmental neurobiology, 2020, PMID:31587468)

📖 View canonical wiki page →

Related Entities

EFNB2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-efnb2
kg_node_id	EFNB2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-2892f26df1f3
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-efnb2'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

30%

Debates

0

Incoming

6

Outgoing

14

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

EFNB2 — Ephrin B2

EFNB2 — Ephrin B2

Overview

EFNB2 — Ephrin B2

Overview

Gene Family

Protein Structure and Biochemistry

Extracellular Domain

Transmembrane Region

Intracellular (Cytoplasmic) Domain

Bidirectional Signaling

Expression Pattern

Developmental Expression

Adult Brain Expression

Cellular Localization

Function in Normal Physiology

Neural Development

Synaptic Plasticity

Neurovascular Coupling

Cell-Cell Communication

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Signaling Pathways

Forward Signaling (via Eph Receptors)

Reverse Signaling

Interacting Proteins and Receptors

Primary Receptors

Other Interacting Proteins

Research Models and Tools

Animal Models

Cell Models

Experimental Approaches

Therapeutic Implications

Drug Development

Biomarker Potential

Summary and Key Points

Recent Research Developments

Novel Therapeutic Approaches

Biomarker Development

Structural Studies

Clinical Trials and Therapeutic Developments

Active Clinical Trials

Therapeutic Approaches

Metabolic Integration

Neurovascular Coupling

Calcium Homeostasis

Animal Models and Research

In Vivo Models

In Vitro Models

Research Tools

Research Directions

Current Focus Areas

Emerging Technologies

See Also

Molecular Mechanisms

Receptor Binding and Activation

Cytoplasmic Signaling Domains

Downstream Effectors

Clinical Relevance

Therapeutic Target Potential

Biomarker Applications

Evolutionary Context

Conservation Across Species

Relationship to Other Ephrins

Research Methodologies

Molecular Techniques

In Vivo Models

Ephrin/Eph System in Neuroinflammation

Microglial Activation

Astrocyte Involvement

Synaptic Circuit Remodeling

Activity-Dependent Plasticity

Homeostatic Plasticity

Structural Biology

Protein Domain Architecture

Crystallography Studies

Therapeutic Development